Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eqt Ab

Start price
Target price
Perf. (%)
€25.61
20.12.23
-
20.12.24
-3.48%
31.01.24

buy
Mereo Biopharma Group Ltd.

Start price
Target price
Perf. (%)
€1.95
19.12.23
-
19.12.24
6.67%
23.12.23

Could be worthwhile Investment >10% per year
buy
Vimeo Inc.

Start price
Target price
Perf. (%)
€3.76
19.12.23
-
19.12.24
0.53%
15.02.24

D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.91
18.12.23
€1.00
18.12.24
-10.50%
29.12.23

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Antares Vision S.p.a.

Start price
Target price
Perf. (%)
€1.66
16.12.23
-
16.12.24
46.14%
18.03.24

buy
Black Swan Graphene Inc.

Start price
Target price
Perf. (%)
€0.050
15.12.23
€0.000
31.12.28
-8.00%
21.12.23

Revenue growth >5% per year expected
Risky Investment
EBIT decline/stagnation expected
buy
Pagerduty Inc.

Start price
Target price
Perf. (%)
€21.50
15.12.23
-
15.12.24
5.58%
15.02.24

buy
D-wave Quantum Inc.

Start price
Target price
Perf. (%)
€0.95
14.12.23
€1.00
14.12.24
-5.14%
18.12.23

Fair valuation
Small cyclical dependencies
Revenue growth >5% per year expected
EBIT growth >5% per year expected
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€21.60
13.12.23
€22.00
13.12.24
1.62%
23.01.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Clearmind Medicine Inc.

Start price
Target price
Perf. (%)
€2.81
11.12.23
-
11.12.24
-8.54%
23.12.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€2.75
10.12.23
€3.50
31.03.26
-3.09%
24.12.23

Could be very worthwhile Investment >20% year
Anixa Biosciences Inc.

Start price
Target price
Perf. (%)
€3.78
09.12.23
€1.00
09.12.24
-7.41%
23.12.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Hut 8 Corp.

Start price
Target price
Perf. (%)
€9.41
09.12.23
-
09.12.24
1.98%
15.02.24

buy
Redhill Biopharma Ltd.

Start price
Target price
Perf. (%)
€1.07
07.12.23
-
07.12.24
17.76%
08.12.23

Could be very worthwhile Investment >20% year
buy
Japan Gold

Start price
Target price
Perf. (%)
€0.18
06.12.23
€0.10
-
10.12.23

Could be worthwhile Investment >10% per year
buy
Cliq Digital AG

Start price
Target price
Perf. (%)
€20.50
05.12.23
€22.00
05.12.24
5.37%
13.12.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Cloudflare Inc.

Start price
Target price
Perf. (%)
€73.44
05.12.23
-
05.12.24
1.28%
31.01.24

buy
Bit Brother Ltd.

Start price
Target price
Perf. (%)
€0.070
02.12.23
€0.060
31.01.26
-77.86%
10.12.23

Could be very worthwhile Investment >20% year
buy
Exagen Inc.

Start price
Target price
Perf. (%)
€1.71
02.12.23
€2.60
31.12.25
-
04.12.23

Could be very worthwhile Investment >20% year
buy
Vinfast Auto Pte. Ltd

Start price
Target price
Perf. (%)
€8.85
30.11.23
-
30.11.24
-28.25%
09.12.23

Capable Management
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Few uniques
buy
Clearmind Medicine Inc.

Start price
Target price
Perf. (%)
€6.10
30.11.23
€12.00
30.11.24
-50.16%
09.12.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
buy
Affirm Hldgs Inc

Start price
Target price
Perf. (%)
€31.50
30.11.23
-
30.11.24
23.17%
31.01.24

Redhill Biopharma Ltd.

Start price
Target price
Perf. (%)
€2.71
29.11.23
€0.30
29.11.24
-81.33%
19.02.24

Capable Management
Bad rating
Below average Marketposition
EBIT decline/stagnation expected
Redhill Biopharma Ltd.

Start price
Target price
Perf. (%)
€1.76
28.11.23
€0.000
28.11.24
-28.50%
09.12.23

Little Investments for future growth
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Torm Plc

Start price
Target price
Perf. (%)
€28.32
28.11.23
€36.00
28.11.25
5.65%
16.01.24

Very high dividend yield expected
Some uniques
Stable Large shareholder and/or long term investor